Amphastar Pharmaceuticals

$17.33
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.22 (+1.29%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell AMPH and other stocks, options, and ETFs commission-free!

About AMPH

Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and intranasal products. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments.

CEO
Yong Feng Zhang
Employees
1,980
Headquarters
Rancho Cucamonga, California
Founded
1996
Market Cap
854.20M
Price-Earnings Ratio
598.25
Dividend Yield
—
Average Volume
172.81K
High Today
$17.54
Low Today
$17.14
Open Price
$17.14
Volume
156.24K
52 Week High
$22.69
52 Week Low
$15.50

AMPH Earnings

$0.00
$0.06
$0.11
$0.17
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, After Hours

You May Also Like

BEKE
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure